Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827826 · ClinicalTrials.gov registry record · NA
Call-2-Health: Preventing Type II Diabetes
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT01827826 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 47 participants.
The verdict
NCT01827826, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
It is estimated that 30 million U.S. adults will have type 2 diabetes by 2050. Contributing to this national trend is the obesity epidemic. Three randomized trials have demonstrated that intensive behavioral interventions can prevent or delay the onset of diabetes. The purpose of this pilot study is to inform a future randomized, controlled Phase III trial of a population-based, telephonic, exercise and weight loss intervention to translate the findings of the Diabetes Prevention Program into practice. The telephonic intervention will be compared to usual care (30 participants in each group). The investigators will deliver the intervention in 12 weekly, 20-minute calls, with four subsequent maintenance calls, for a total of 16 calls over 24 weeks. Study outcomes will be measured at baseline and at 12 and 24 weeks. For this planning grant the investigators do not have an overall hypothesis. The investigators' goal is to develop and test whether it is possible to do exercise and weight loss
Interventions
- BEHAVIORAL Telephonic intervention to prevent Diabetes Mellitus, Type 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01827826
The ClinicalTrials.gov registry entry for NCT01827826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telephonic intervention to prevent Diabetes Mellitus, Type 2 is the first listed.
NCT01827826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01827826 about?
NCT01827826 is a clinical study titled "Call-2-Health: Preventing Type II Diabetes". It is estimated that 30 million U.S. adults will have type 2 diabetes by 2050. Contributing to this national trend is the obesity epidemic. Three randomized trials have demonstrated that intensive behavioral interventions can prevent or delay the onset of diabetes. The purpose of this pilot study is...
What is the current status of trial NCT01827826?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2010-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01827826?
The interventions under investigation include: Telephonic intervention to prevent Diabetes Mellitus, Type 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01827826?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.